Implantable-cardioverter-defibrillator after ST-elevation myocardial infarction: when and how frequently is it implanted and what is the rate of appropriate interventions? Insight from Trieste registry

Effect of prehospital treatment in STEMI patients undergoing primary PCI

(2022) Enrico Fabris et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies

(2022) Stefan Frantz et al.   EUROPEAN HEART JOURNAL

From mid-range to mildly reduced ejection fraction heart failure: A call to treat

(2022) Davide Stolfo et al.   European Journal of Internal Medicine

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

(2022) Katja Zeppenfeld et al.   EUROPEAN HEART JOURNAL

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

(2021) Uwe Zeymer et al.   EUROPEAN HEART JOURNAL

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2021) Theresa A McDonagh et al.   EUROPEAN HEART JOURNAL

STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation

(2021) Enrico Fabris et al.   Heart Lung and Circulation

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials

(2021) Danielle Haanschoten et al.   Arrhythmia & Electrophysiology Review

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

(2020) Kieran F Docherty et al.   EUROPEAN HEART JOURNAL

Arrhythmic event prediction in patients with heart failure and reduced ejection fraction

(2020) Gloria Santangelo et al.   Journal of Cardiovascular Medicine

Long-term Outcome of the Randomized Defibrillator After Primary Angioplasty (DAPA) Trial

(2020) Danielle M. Haanschoten et al.   Circulation-Arrhythmia and Electrophysiology

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

(2020) Milton Packer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach

(2019) Enrico Fabris et al.   DRUGS

Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

(2019) James L. Januzzi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience

(2019) Stefano Albani et al.   European Heart Journal-Acute Cardiovascular Care

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system

(2016) Benjamin K. Johnson et al.   HEART RHYTHM

Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry

(2015) Avi Sabbag et al.   HEART RHYTHM

Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks

(2013) Paul Blanche et al.   STATISTICS IN MEDICINE

Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction

(2010) Daniel G. Kramer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY